Entdecken Sie eine Karriere mit tieferem Sinn

Accountabilities

SupportscountrySSUstrategyinclosecollaborationwithSSOStudyStart-UpTeamLead,SSO CountryHeadPortfolio/SSOClusterHeadPortfolio

CollaborateswithSSOCountry/ClusterHeadPortfolio,SSOPortfolioTeamLeadsandglobal studyteamtoensureSSUtimelinesanddeliverablesaremetaccordingtocountrycommitments.

Accountable for timely start-up activities from country allocation until Green Light (readyto initiatesitemillstone)inassignedprojects.

EnsuresclosecollaborationwithlocalIRBs/IECsandHealthAuthorities,asapplicable.

• Ensures that study start-up activities are conducted and completed on time, including preparation of IRB/IEC submission packages, review of Informed Consent Forms, engaging Regulatory Affairs/CTA Hub for Health Authorities submissions, as required.
• Prepares and finalizes local submission package for submission to IRB/IEC, CTA Hub (Europe: acc. to new EU-CTR) as well as Health Authorities as applicable (including subsequent amendments, IBs, DSURs, CSRs)
• Coordinates timely response to deficiency letters in close collaboration with local and global stakeholders.
• Coordinates reportable events and notifications to IRB/IEC and Health Authorities as applicable.
• Accountable for timelines, accuracy, and quality of country TMF documents in study start-up to ensure TMF inspection readiness.
• Ensures adherence to financial standards, prevailing legislation, ICH/GCP, IRB/IEC, Health Authority and SOP requirements.
• Implements innovative and efficient processes.
• Supports study feasibility in close collaboration with Feasibility Manager and Site Partnership Manager as well as the global study team.
• Leads site selection in collaboration with Portfolio Team Lead and Clinical Project Manager if already assigned.
• In satellite countries oversees local vendor selection and performance as needed.
• Serves as main contact for quality/compliance issues in SSU phase, escalating as necessary.
• Ensures sites are prepared for "Green Light" and ensure all documentations is in place for initial and subsequent drug release.
• Responsible for review and sign off of site "Green Light".
• Oversees local SSU team activities in assigned studies to achieve start-up timelines and quality execution, (proposing and implementing corrective actions where appropriate) according to local and international regulations.
• Leads/chairs local SSU team meetings in assigned studies, participates in global study team meetings, as required.
• Leads the development of country site initiation and patient enrolment plans together with SSU CRA, CPM and SSU Lead.

IQVIA is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. We create intelligent connections to accelerate the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide. Learn more at https://jobs.iqvia.com